GB2262286B - Products and processes for the treatment of the alimentary canal - Google Patents
Products and processes for the treatment of the alimentary canalInfo
- Publication number
- GB2262286B GB2262286B GB9300652A GB9300652A GB2262286B GB 2262286 B GB2262286 B GB 2262286B GB 9300652 A GB9300652 A GB 9300652A GB 9300652 A GB9300652 A GB 9300652A GB 2262286 B GB2262286 B GB 2262286B
- Authority
- GB
- United Kingdom
- Prior art keywords
- pct
- treatment
- bismuth
- products
- processes
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4891—Coated capsules; Multilayered drug free capsule shells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/65—Tetracyclines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/245—Bismuth; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/52—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an inorganic compound, e.g. an inorganic ion that is complexed with the active ingredient
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/58—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Inorganic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Dental Tools And Instruments Or Auxiliary Dental Instruments (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Inorganic Compounds Of Heavy Metals (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Saccharide Compounds (AREA)
- Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB909015988A GB9015988D0 (en) | 1990-07-20 | 1990-07-20 | Pharmaceutical composition |
GB919101675A GB9101675D0 (en) | 1991-01-25 | 1991-01-25 | Pharmaceutical composition |
GB9103795A GB2253346A (en) | 1991-02-22 | 1991-02-22 | Delayed release oral dosage forms for treatment of intestinal disorders |
PCT/GB1991/001209 WO1992001457A1 (en) | 1990-07-20 | 1991-07-19 | Products and processes for the treatment of the alimentary canal |
Publications (3)
Publication Number | Publication Date |
---|---|
GB9300652D0 GB9300652D0 (en) | 1993-03-10 |
GB2262286A GB2262286A (en) | 1993-06-16 |
GB2262286B true GB2262286B (en) | 1994-10-12 |
Family
ID=27265192
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB9300652A Expired - Fee Related GB2262286B (en) | 1990-07-20 | 1993-01-14 | Products and processes for the treatment of the alimentary canal |
Country Status (19)
Country | Link |
---|---|
US (1) | US5843482A (cs) |
EP (1) | EP0540613B1 (cs) |
JP (1) | JP2688541B2 (cs) |
KR (1) | KR100193933B1 (cs) |
AT (1) | ATE135227T1 (cs) |
AU (1) | AU648574B2 (cs) |
BG (1) | BG62037B1 (cs) |
CA (1) | CA2087596A1 (cs) |
CZ (1) | CZ386292A3 (cs) |
DE (1) | DE69117955T2 (cs) |
DK (1) | DK0540613T3 (cs) |
ES (1) | ES2084174T3 (cs) |
FI (1) | FI97952C (cs) |
GB (1) | GB2262286B (cs) |
GR (1) | GR3019790T3 (cs) |
HU (1) | HUT64080A (cs) |
IE (1) | IE65964B1 (cs) |
NO (2) | NO302684B1 (cs) |
WO (1) | WO1992001457A1 (cs) |
Families Citing this family (40)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0995447A1 (en) * | 1993-09-09 | 2000-04-26 | Takeda Chemical Industries, Ltd. | Formulation comprising antibacterial substance and antiulcer substance |
US5549911A (en) * | 1994-01-14 | 1996-08-27 | Laboratoires Des Produits Ethiques Ethypharm | Galenic form of 5-nitromidazole derivatives which is effective for the treatment of parasitoses and infections of the entire gastrointestinal tract |
SE502628C2 (sv) * | 1994-02-04 | 1995-11-27 | Nobel Chemicals Ab | Förfarande för framställning av ett vattenlösligt komplex av vismut och en polyakrylsyra |
US6426085B1 (en) | 1994-05-02 | 2002-07-30 | Josman Laboratories Inc. | Use of bismuth-containing compounds in topical oral dosage forms for the treatment of halitosis |
US6902738B2 (en) | 1994-05-02 | 2005-06-07 | Josman Laboratories, Inc. | Topical oral dosage forms containing bismuth compounds |
US5834002A (en) | 1994-05-02 | 1998-11-10 | Josman Laboratories, Inc. | Chewing gum containing colloidal bismuth subcitrate |
GB9414699D0 (en) * | 1994-07-21 | 1994-09-07 | Slagel David | Aqueous foamable composition |
HUP9900428A2 (hu) * | 1995-01-26 | 1999-06-28 | Nycomed Imaging A/S | Bizmutvegyületek, ezeket tartalmazó diagnosztikai kontrasztanyag, ennek alkalmazása és ezt tartalmazó gyógyászati készítmény |
GB9501560D0 (en) * | 1995-01-26 | 1995-03-15 | Nycomed Imaging As | Contrast agents |
US6372784B1 (en) | 1995-02-07 | 2002-04-16 | Josman Laboratories, Inc. | Bismuth-containing compounds in topical dosage forms for treatment of corneal and dermal wounds |
US6379651B1 (en) | 1995-02-07 | 2002-04-30 | Josman Laboratories | Oral-topical dosage forms for delivering antibacterials/antibiotics to oral cavity to eradicate H. pylori as a concomitant treatment for peptic ulcers and other gastro-intestinal diseases |
US7048906B2 (en) * | 1995-05-17 | 2006-05-23 | Cedars-Sinai Medical Center | Methods of diagnosing and treating small intestinal bacterial overgrowth (SIBO) and SIBO-related conditions |
US5744168A (en) * | 1995-12-07 | 1998-04-28 | The Procter & Gamble Company | Methods and compositions for the prevention and treatment of gastrointestinal disorders |
CA2239422C (en) * | 1995-12-07 | 2003-03-11 | The Procter & Gamble Company | Compositions, containing bismuth, for the prevention and treatment of gastrointestinal disorders |
US6051604A (en) * | 1995-12-07 | 2000-04-18 | The Proctor & Gamble Company | Methods and compositions for the prevention and treatment of gastrointestinal disorders |
US5702729A (en) * | 1995-12-07 | 1997-12-30 | The Procter & Gamble Company | Methods for the prevention and treatment of gastrointestinal disorders caused or mediated by algae or cyanobacteria |
US5827543A (en) * | 1995-12-07 | 1998-10-27 | The Procter & Gamble Company | Methods and compositions for the prevention and treatment of urogenital disorders |
EP0776665B1 (en) * | 1995-12-07 | 2003-02-19 | The Procter & Gamble Company | Compositons for the prevention and treatment of urogenital disorders, containing bismuth |
US5889028A (en) * | 1996-02-09 | 1999-03-30 | Mayo Foundation For Medical Education And Research | Colonic delivery of nicotine to treat inflammatory bowel disease |
US5846983A (en) * | 1996-02-09 | 1998-12-08 | Mayo Foundation For Medical Education And Research | Colonic delivery of nicotine to treat inflammatory bowel disease |
GB9607955D0 (en) * | 1996-04-17 | 1996-06-19 | Tillotts Pharma Ag | Hydrophobic carbomer salt compositions |
GB9620709D0 (en) * | 1996-10-04 | 1996-11-20 | Danbiosyst Uk | Colonic delivery of weak acid drugs |
GB9623962D0 (en) * | 1996-11-15 | 1997-01-08 | Tillotts Pharma Ag | Pharmaceutical composition |
US6114382A (en) * | 1998-11-11 | 2000-09-05 | Moretti; Itagiba G. | Methods for treating inflammatory bowel disease |
IN191482B (cs) * | 1999-03-19 | 2003-12-06 | Ranbaxy Lab Ltd | |
DE60143360D1 (de) * | 2000-08-03 | 2010-12-09 | Antares Pharma Ipl Ag | Zusammensetzung zur transdermalen und/oder transmukosalen Verabreichung von Wirkstoffen, die ausreichende therapeutische Spiegel garantiert |
US8980290B2 (en) | 2000-08-03 | 2015-03-17 | Antares Pharma Ipl Ag | Transdermal compositions for anticholinergic agents |
US7198801B2 (en) | 2000-08-03 | 2007-04-03 | Antares Pharma Ipl Ag | Formulations for transdermal or transmucosal application |
JP4947851B2 (ja) * | 2001-06-07 | 2012-06-06 | 信紘 佐藤 | 潰瘍性大腸炎治療薬 |
MXPA06003316A (es) | 2003-10-10 | 2006-06-08 | Antares Pharma Ipl Ag | Formulacion farmaceutica transdermica para minimizar los residuos en la piel. |
GB0403247D0 (en) | 2004-02-13 | 2004-03-17 | Tillotts Pharma Ag | A pharmaceutical composition |
US8067399B2 (en) | 2005-05-27 | 2011-11-29 | Antares Pharma Ipl Ag | Method and apparatus for transdermal or transmucosal application of testosterone |
CN101426475A (zh) | 2006-04-21 | 2009-05-06 | 安塔雷斯制药Ipl股份公司 | 使用用于经皮或经粘膜应用的制剂治疗热潮红的方法 |
WO2008052294A1 (en) * | 2006-10-30 | 2008-05-08 | Universidade Federal De Minas Gerais | Preparation of compounds of cyclodextrins and derivatives thereof with bismuth compounds |
US20120053239A1 (en) * | 2006-12-07 | 2012-03-01 | Eli Ehrenpreis | Treatment for intestinal gas, bloating, microscopic colitis, inflammatory bowel disease and traveler's diarrhea using colloidal bismuth subcitrate |
US7645801B2 (en) * | 2007-01-29 | 2010-01-12 | Alaven Pharmaceutical Llc | Reduced irritant enema for treatment of inflammatory bowel disease (IBD) |
US20080188445A1 (en) * | 2007-02-02 | 2008-08-07 | Warner Chilcott Company Inc. | Tetracycline compositions for topical administration |
WO2008097851A1 (en) * | 2007-02-02 | 2008-08-14 | Warner Chilcott Company, Inc. | Tetracycline compositions for topical administration |
RU2605615C2 (ru) * | 2014-07-15 | 2016-12-27 | Общество с ограниченной ответственностью "Гелизовит" | Ректальный поликомплексный гель для лечения язвенного колита, болезни крона, свищей и осложнений, вызванных этими заболеваниями |
WO2024022447A1 (zh) * | 2022-07-29 | 2024-02-01 | 上海交通大学 | 铋-高分子复合物在消化道可视化中的用途 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3887448A (en) * | 1972-04-19 | 1975-06-03 | Norddeutsche Affinerie | Method of preventing supersaturation of electrolytes with arsenic, antimony and bismuth |
DE2501787C2 (cs) * | 1974-01-18 | 1987-11-12 | Gist-Brocades N.V., Delft, Nl |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
HU179474B (en) * | 1978-02-24 | 1982-10-28 | Laszlo Gyarmati | Process for preparing solid oral pharmaceutical compositons with increased length of activity and with a regulated release of the active material |
EP0217440A1 (en) * | 1985-09-27 | 1987-04-08 | The Procter & Gamble Company | Stable aqueous pharmaceutical suspensions |
US4837378A (en) * | 1986-01-15 | 1989-06-06 | Curatek Pharmaceuticals, Inc. | Topical metronidazole formulations and therapeutic uses thereof |
DE3874917T2 (de) * | 1987-03-09 | 1993-03-04 | Procter & Gamble | Zusammensetzungen und ihre verwendung zur behandlung von magen-darmstoerungen. |
IL85472A (en) * | 1987-03-09 | 1991-06-30 | Procter & Gamble | Pharmaceutical compositions for treating gastrointestinal disorders |
EP0439453B1 (en) * | 1987-10-12 | 1994-01-19 | Exomed Australia Pty. Ltd. (ACN 051 976 446) | Improved method for treatment of gastrointestinal disorders |
US4940695A (en) * | 1987-12-10 | 1990-07-10 | The Procter & Gamble Company | Bismuth-containing pharmaceutical compositions |
GB8817015D0 (en) * | 1988-07-16 | 1988-08-17 | Reckitt & Colmann Prod Ltd | Method of treatment |
CH679582A5 (cs) * | 1988-07-18 | 1992-03-13 | Glaxo Group Ltd | |
AU641903B2 (en) * | 1988-10-26 | 1993-10-07 | Glaxo Group Limited | Carboxylic acid derivatives |
US5128140A (en) * | 1991-01-14 | 1992-07-07 | The Procter & Gamble Company | Swallowable pharmaceutical compositions |
-
1991
- 1991-07-19 WO PCT/GB1991/001209 patent/WO1992001457A1/en not_active Application Discontinuation
- 1991-07-19 ES ES91913651T patent/ES2084174T3/es not_active Expired - Lifetime
- 1991-07-19 KR KR1019930700162A patent/KR100193933B1/ko not_active IP Right Cessation
- 1991-07-19 US US07/966,163 patent/US5843482A/en not_active Expired - Fee Related
- 1991-07-19 DE DE69117955T patent/DE69117955T2/de not_active Expired - Fee Related
- 1991-07-19 EP EP91913651A patent/EP0540613B1/en not_active Expired - Lifetime
- 1991-07-19 CA CA002087596A patent/CA2087596A1/en not_active Abandoned
- 1991-07-19 AU AU82348/91A patent/AU648574B2/en not_active Ceased
- 1991-07-19 HU HU93133A patent/HUT64080A/hu unknown
- 1991-07-19 DK DK91913651.5T patent/DK0540613T3/da active
- 1991-07-19 JP JP3512557A patent/JP2688541B2/ja not_active Expired - Lifetime
- 1991-07-19 AT AT91913651T patent/ATE135227T1/de not_active IP Right Cessation
- 1991-07-19 IE IE254691A patent/IE65964B1/en not_active IP Right Cessation
- 1991-09-27 CZ CS923862A patent/CZ386292A3/cs unknown
-
1992
- 1992-12-28 FI FI925893A patent/FI97952C/fi active
-
1993
- 1993-01-14 GB GB9300652A patent/GB2262286B/en not_active Expired - Fee Related
- 1993-01-19 NO NO930176A patent/NO302684B1/no not_active IP Right Cessation
- 1993-02-17 BG BG97458A patent/BG62037B1/bg unknown
-
1996
- 1996-04-29 GR GR960401170T patent/GR3019790T3/el unknown
-
1997
- 1997-12-08 NO NO975779A patent/NO306046B1/no not_active IP Right Cessation
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3887448A (en) * | 1972-04-19 | 1975-06-03 | Norddeutsche Affinerie | Method of preventing supersaturation of electrolytes with arsenic, antimony and bismuth |
DE2501787C2 (cs) * | 1974-01-18 | 1987-11-12 | Gist-Brocades N.V., Delft, Nl |
Non-Patent Citations (1)
Title |
---|
Derwent's abstract no. 108 79 B/06, JP 53 148 538, pub1. week 7906 * |
Also Published As
Publication number | Publication date |
---|---|
GB9300652D0 (en) | 1993-03-10 |
NO930176L (no) | 1993-01-19 |
KR100193933B1 (ko) | 1999-06-15 |
NO302684B1 (no) | 1998-04-14 |
ES2084174T3 (es) | 1996-05-01 |
HUT64080A (en) | 1993-11-29 |
DK0540613T3 (da) | 1996-04-01 |
NO306046B1 (no) | 1999-09-13 |
JP2688541B2 (ja) | 1997-12-10 |
DE69117955T2 (de) | 1996-09-19 |
WO1992001457A1 (en) | 1992-02-06 |
AU8234891A (en) | 1992-02-18 |
IE65964B1 (en) | 1996-01-24 |
EP0540613A1 (en) | 1993-05-12 |
CZ386292A3 (en) | 1993-12-15 |
GB2262286A (en) | 1993-06-16 |
CA2087596A1 (en) | 1992-01-21 |
DE69117955D1 (de) | 1996-04-18 |
NO975779L (no) | 1997-12-08 |
EP0540613B1 (en) | 1996-03-13 |
ATE135227T1 (de) | 1996-03-15 |
FI925893A (fi) | 1992-12-28 |
BG97458A (bg) | 1994-03-31 |
FI97952C (fi) | 1997-03-25 |
JPH06502431A (ja) | 1994-03-17 |
NO975779D0 (no) | 1997-12-08 |
AU648574B2 (en) | 1994-04-28 |
BG62037B1 (bg) | 1999-01-29 |
NO930176D0 (no) | 1993-01-19 |
US5843482A (en) | 1998-12-01 |
HU9300133D0 (en) | 1993-04-28 |
IE912546A1 (en) | 1992-01-29 |
FI97952B (fi) | 1996-12-13 |
GR3019790T3 (en) | 1996-07-31 |
FI925893A0 (fi) | 1992-12-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB2262286B (en) | Products and processes for the treatment of the alimentary canal | |
IL111077A (en) | Pyridine derivatives processes for the preparation thereof and pharmaceutical compositions containing them | |
GR3022116T3 (en) | Thiazolidin-2,4-dione derivatives, process for their preparation and pharmaceutical compositions containing them | |
MY115351A (en) | Pharmaceutical formulations | |
LTIP1920A (en) | Veterinary composition and process for preparing thereof | |
NO951198L (no) | Lipopeptidderivater, fremgangsmåte for fremstilling derav og anvendelse av derivatene | |
ZW9788A1 (en) | New diazoles | |
IT1262993B (it) | Complesso di bismuto citrato di ranitidina ed antibiotico, composizione che lo contiene e relativo metodo di produzione ed impiego | |
HUP0201631A2 (hu) | Alkalikus szfingomielinázt tartalmazó dietetikus készítmények, ételkiegészítők és gyógyászati termékek | |
NZ227990A (en) | Cephemcarboxylic acid esters; pharmaceutical compositions and processes for preparation | |
GR3036873T3 (en) | Dialkyltiacumicin compounds | |
DE3260277D1 (en) | Peptide antibiotic, component b, process for its preparation and its use in medicines | |
IL87197A0 (en) | Leukotriene antagonists,precursors of same,processes for the preparation thereof and pharmaceutical compositions containing same | |
IL89126A0 (en) | Beta-lactam antibiotics,their preparation and pharmaceutical compositions containing them | |
ZA828127B (en) | Pyridazinone-imines and their physiologically tolerated acid addition salts, their preparation, and therapeutic agents containing these compounds | |
JPS53144502A (en) | New antibiotics tridecaptin b and its preparation | |
JPS5210425A (en) | An antibiotic pharmaceutical with low reaction |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PCNP | Patent ceased through non-payment of renewal fee |
Effective date: 19960719 |